Ghost Tree Capital, LLC Sage Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$54.88 - $79.29 $1.65 Million - $2.38 Million	-30,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $2.12 Million - $2.9 Million	30,000 New	30,000 $2.25 Million
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $1.69 Million - $2.8 Million	-65,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $1.7 Million - $5.02 Million	65,000 New	65,000 $1.87 Million
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $6.62 Million - $17 Million	-110,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $11.2 Million - $15.2 Million	80,000 Added 266.67%	110,000 $15.4 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $7.1 Million - $8.24 Million	-45,000 Reduced 60.0%	30,000 $5.49 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $6.4 Million - $11.7 Million	71,700 Added 2172.73%	75,000 $11.9 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $508,028 - $866,202	-6,200 Reduced 65.26%	3,300 $316,000
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $1.31 Million - $1.61 Million	9,500 New	9,500 $1.34 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $1.56 Million - $1.95 Million	-11,100 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $1.59 Million - $2.01 Million	-10,437 Reduced 48.46%	11,100 $1.79 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $1.31 Million - $3.6 Million	21,537	21,537 $3.55 Million

191

45.7M

385K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $427M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.